Back to Search
MARC FISHMAN, MD
MD
Hematology & Oncology Physician
NPI: 1801013735Individual
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
ME40052(FL)
Research & Publications (20)
Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma.
PMID 18157014·J Immunother·2008
3-trial
Phase I study of the taxane BMS-188797 in combination with carboplatin administered every 3 weeks in patients with solid malignancies.
PMID 16428495·Clin Cancer Res·2006
3-trial
Cell-based immune therapy for metastatic renal cancer.
PMID 14686706·Expert Rev Anticancer Ther·2003
6-review
Novel therapies for renal cell carcinoma--an update.
PMID 12665415·Expert Opin Investig Drugs·2003
6-review
Application of Resistance Reversal Agents in Hematologic Malignancies; Malignancy; Current Clinical Practice.
PMID 11399634·Hematology·2001
8-other
A single serine in the carboxyl terminus of cardiac essential myosin light chain-1 controls cardiomyocyte contractility in vivo.
PMID 19168438·Circ Res·2009
7-preclinical
Mutations in zebrafish leucine-rich repeat-containing six-like affect cilia motility and result in pronephric cysts, but have variable effects on left-right patterning.
PMID 19395640·Development·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 670 NW 101ST TER
PLANTATION, FL 33324 - Phone
- (954) 562-4884
Quick Facts
- NPI
- 1801013735
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile